Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

July 27, 2020

Linda Clark and Brad Gallagher Published on Pharmacy Insider Blog

Linda Clark, Health Care Controversies Team leader, and Brad Gallagher, counsel, recently had their “Caremark’s Bold Move to Restrict Dispensing and Access to Products on the Formulary” article published on the Pharmacy Insider blog.

“Suspect product” lists have been used for years by pharmacy benefit managers (PBMs) to target independent pharmacies and subject them to heightened scrutiny. These lists often target high margin products or other drugs that, for other unknown reasons, may be disfavored by PBMs without regard to formularies of individual plans. The lists are secret, and only “word-of-mouth” through the experiences of other network pharmacies do we learn of the targeted products or manufacturers.”

Read the full article here.

Featured Media

Alerts

New York State Department of Labor Issues Guidance on the Trapped at Work Act

Alerts

Breaking News: New York State Announces Advanced Nuclear Master Plan

Alerts

What Pharmacies Need to Know About the DOL's PBM Transparency Rule

Alerts

Changes to Florida's Homestead Exemption Are Coming: Why 2026 Is Now an Important Residency Deadline

Alerts

EEOC Rescinds Employee Criminal-History Guidance: What Employers Should Know

Alerts

DOL Withdraws Decades-Old Tip Credit Guidance: What Hospitality Employers Should Know About Dual Jobs and the Status of the 80/20 Rule